Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
ASCO
Dec 19, 2023, 18:22 |
Blog
Fumiko Chino: what still surprises me is how many times *I cry*
Fumiko Chino shared on X/Twitter: ''Every week I fold cranes for my patients who complete…
Dec 19, 2023, 00:03 |
Blog
Julie Gralow: Thank you Foreign Policy, Burjeel Holdings for hosting a dynamic summit on The Future of Cancer Care!
Julie Gralow shared the following post on Twitter: “Thank you Foreign Policy, Burjeel Holdings for hosting…
Dec 18, 2023, 21:06 |
Insight
Toni Choueiri: A new option for our Kidney Cancer patients!
Toni Choueiri shared on LinkedIn: "JUST IN: FDA approved belzutifan (HIF2 inhibitor) in advanced renal cell…
Dec 16, 2023, 11:19 |
Insight
Caryn Lerman: Heinz Josef Lenz and his team identified novel predictive and prognostic biomarkers
Caryn Lerman, Director of USC Norris Comprehensive Cancer Center, shared on LinkedIn: "Published in the…
Dec 13, 2023, 17:58 |
Blog
Justin Stebbing: My piece on genes and race in colon cancer has just been published by the Journal of Clinical Oncology
Justin Stebbing shared a post on LinkedIn: "My piece on genes and race in colon cancer…
Dec 13, 2023, 17:53 |
Blog
Earle Burgess: Why don’t all advanced prostate cancer patients with pathogenic HRR gene mutations respond to parp inhibitors?
Earle Burgess, Chief of Genitourinary Oncology Section at Atrium Health, Levine Cancer Institute, shared a…
Dec 12, 2023, 11:42 |
Insight
Shruti Jolly: Treating lung cancer with immunotherapy and radiation without chemotherapy
Shruti Jolly, Associate Director for the Statewide Cancer Network at Michigan Medicine, shared on LinkedIn:…
Dec 12, 2023, 03:40 |
Dialogues
OncoInfluencers: Dialogue with Dean Crowe, hosted by Gevorg Tamamyan
Join us for an exciting new episode of "OncoInfluencers," hosted by Dr. Gevorg Tamamyan. In…
Dec 12, 2023, 00:02 |
Opinion
David Steensma: There have been so many developments over the years in The American Society of Hematology (ASH) annual meeting
David Steensma, Chief Medical Officer at Ajax Therapeutics, made the following post on Twitter: "There have…
Dec 10, 2023, 18:01 |
Insight
Giselle Sholler: Our research that led to the FDA-Oncologic Drugs Advisory Committee 70% approval for moving Difluoromethylornithine forward
Giselle Sholler, Division Chief Pediatric Hematology/Oncology/BMT at Penn State Health Children's Hospital, shared on LinkedIn:…
262
263
264
265
266
All:
2870
Posts:
2631 - 2640
Tsetsegsaikhan Batmunkh: Honored to be nominated for the board of directors of the UICC
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
MASCC24 Highlights: The Ideal Location for Care Varies According to Disease, Patient and Family Characteristics
Facebook
RSS Feed
Twitter
Linkedin
Youtube